← Leaderboards
Thomas Weimbs
Cleveland Clinic Foundation
$9,566,724
Attributed
$9,566,724
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $738.6K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,566,724 · 7
By mechanism
R01$8,887,192 · 5
R21$679,532 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsMouse ModelCystAffectCellsDisease ProgressionClinical TrialsCystic KidneyEpithelial CellsGrowthKidney FailureMdck CellAutosomal Dominant Polycystic KidneyDesignProteinsKidneyFutureLifeSignal TransductionPolycystic Kidney Disease 1 ProteinPolycystic Kidney DiseasesCiliaBaseApical
Grant awards (38)
Ketosis as a therapy for polycystic kidney disease$448,839
R01 · FY2024 · DK · contact PI
Ketosis as a therapy for polycystic kidney disease$481,839
R01 · FY2023 · DK · contact PI
Ketosis as a therapy for polycystic kidney disease$466,483
R01 · FY2022 · DK · contact PI
Ketosis as a therapy for polycystic kidney disease$393,496
R01 · FY2021 · DK · contact PI
Ketosis as a therapy for polycystic kidney disease$393,177
R01 · FY2020 · DK · contact PI
Role of renal crystal deposition in the progression of polycystic kidney disease$345,375
R01 · FY2020 · DK · contact PI
Role of renal crystal deposition in the progression of polycystic kidney disease$345,375
R01 · FY2019 · DK · contact PI
Role of renal crystal deposition in the progression of polycystic kidney disease$345,375
R01 · FY2018 · DK · contact PI
Role of renal crystal deposition in the progression of polycystic kidney disease$345,375
R01 · FY2017 · DK · contact PI
A Novel Role of Syntaxin 3 as a Transcription Regulator$184,607
R21 · FY2013 · DK · contact PI
A Novel Role of Syntaxin 3 as a Transcription Regulator$219,525
R21 · FY2012 · DK · contact PI
STAT Regulation by Polycystin-1$315,531
R01 · FY2011 · DK · contact PI
Regulation of the mTOR pathway in polycystic kidney disease$259,675
R01 · FY2011 · DK · contact PI
Regulation of the mTOR pathway in polycystic kidney disease$69,926
R01 · FY2011 · DK · contact PI
STAT Regulation by Polycystin-1$318,718
R01 · FY2010 · DK · contact PI
Regulation of the mTOR pathway in polycystic kidney disease$265,497
R01 · FY2010 · DK · contact PI
STAT Regulation by Polycystin-1$106,927
R01 · FY2010 · DK · contact PI
STAT Regulation by Polycystin-1$321,937
R01 · FY2009 · DK · contact PI
Regulation of the mTOR pathway in polycystic kidney disease$268,703
R01 · FY2009 · DK · contact PI
Regulation of the mTOR pathway in polycystic kidney disease$8,038
R01 · FY2009 · DK · contact PI
STAT Regulation by Polycystin-1$321,937
R01 · FY2008 · DK · contact PI
Regulation of the mTOR pathway in polycystic kidney disease$269,204
R01 · FY2008 · DK · contact PI
Regulation of the mTOR pathway in polycystic kidney disease$275,160
R01 · FY2007 · DK · contact PI
Syntaxin Function in Cell Polarization$248,101
R01 · FY2007 · GM · contact PI
Syntaxin Function in Cell Polarization$255,511
R01 · FY2006 · GM · contact PI
Epithelial Cell Polarity in Polycystic Kidney Disease$225,726
R01 · FY2006 · DK · contact PI
Epithelial Cell Polarity in Polycystic Kidney Disease$188,589
R01 · FY2005 · DK
Syntaxin Function in Cell Polarization$159,426
R01 · FY2005 · GM
Urinary MMP activity to detect renal cell carcinoma$120,540
R21 · FY2005 · CA
Syntaxin Function in Cell Polarization$106,406
R01 · FY2005 · GM
Epithelial Cell Polarity in Polycystic Kidney Disease$43,283
R01 · FY2005 · DK
Urinary MMP activity to detect renal cell carcinoma$17,160
R21 · FY2005 · CA
Syntaxin Function in Cell Polarization$272,340
R01 · FY2004 · GM
Epithelial Cell Polarity in Polycystic Kidney Disease$240,593
R01 · FY2004 · DK
Urinary MMP activity to detect renal cell carcinoma$137,700
R21 · FY2004 · CA
Syntaxin Function in Cell Polarization$265,220
R01 · FY2003 · GM
Epithelial Cell Polarity in Polycystic Kidney Disease$232,730
R01 · FY2003 · DK
Epithelial Cell Polarity in Polycystic Kidney Disease$282,680
R01 · FY2002 · DK